Last updated: July 28, 2025
Introduction
Patent KR101507648 pertains to a pharmaceutical invention granted by the Korea Intellectual Property Office (KIPO). This patent’s scope, claims, and overall landscape are crucial for pharmaceutical companies, generic entrants, and licensors aiming to operate within or around its protections. This analysis details the patent’s claims, interpretative scope, and positioning within the broader patent environment related to its subject matter.
Patent Overview
KR101507648 was granted to protect a specific pharmaceutical compound, formulation, or method, as per the claim description. Patents in this domain generally cover active ingredients, their synthesis methods, formulations, and therapeutic uses. Based on available data and typical patent annotations, KR101507648 likely addresses a novel drug or a specific formulation with therapeutic advantages.
Note: Official patent documents developed by the KIPO database and associated claims are fundamental in defining the boundaries of patent rights.
Scope of the Invention
The scope of KR101507648 centers around a pharmaceutical composition with specific chemical or biological properties, possibly involving innovative stabilization, delivery mechanisms, or enhanced efficacy. The scope encompasses:
- Compound claims: Specific chemical entities or derivatives.
- Use claims: Therapeutic applications, such as treatments for targeted diseases (e.g., cancer, infectious diseases).
- Process claims: Production methods or synthesis pathways.
- Formulation claims: Specific dosage forms, excipient combinations, or release mechanisms.
The core scope seeks to establish exclusivity over the compound or method described, preventing third parties from manufacturing or commercializing substantially similar substances without authorization.
Claims Analysis
The patent claims define the legal boundary and enforceability. They are categorized into two main types:
- Independent Claims: Broadest scope, establishing the core invention.
- Dependent Claims: Narrower, providing specific embodiments or preferred embodiments.
Key features of the claims include:
- Chemical Structure: If the invention pertains to a novel compound, the claims precisely define the molecular structure, including substitutions, stereochemistry, and functional groups.
- Therapeutic Use: Claims might specify treatment of particular conditions, e.g., "a method of treating cancer comprising administering compound X."
- Synthesis and Formulation Methods: Claims covering novel synthetic routes or formulations that improve stability, bioavailability, or patient compliance.
The scope’s breadth hinges on the specificity of these claims. Overly broad claims risk invalidation if prior art exists; overly narrow claims might allow competitors to design around.
Legal interpretation indicates that the patent protects the compound’s core structure, its pharmaceutically acceptable salts, and potential therapeutically active derivatives, along with specific methods of use.
Patent Landscape Context
The patent landscape involves:
- Prior Art Review: Related compounds, formulations, or methods disclosed before the filing date.
- Related Patents: Overlapping patents may exist, including international counterparts (e.g., WO, US, EU patents) covering similar compounds or methods.
- Patent Families: A well-organized family of patents extending patent rights across jurisdictions.
Key considerations in landscape assessment:
- Novelty and Inventive Step: The invention must demonstrate uniqueness over prior art, which might include earlier compounds or similar therapeutic methods.
- Freedom to Operate (FTO): Companies must evaluate whether other patents block commercialization of similar drugs, especially in overlapping chemical spaces.
- Expiration and Filing Date: KR101507648 was likely filed in the recent decade; its expiry date is approximately 20 years from the filing date unless otherwise extended.
Legal Status and Challenges
The legal standing of KR101507648 appears robust, assuming no oppositions or invalidations have been filed post-grant. However, competitors might challenge the patent’s validity via patent invalidation proceedings, citing prior art or obviousness.
Potential areas of contention:
- Obviousness: Similar compounds or methods are well-documented.
- Insufficient Disclosure: Claims may be broader than what the specification justifies, risking invalidation.
- Freedom to Operate: Other patents may restrict commercialization, especially if overlapping molecular structures are claimed elsewhere.
Innovation Significance and Commercial Implications
Given Korea's prominence in biotech and pharmaceutical R&D, patent KR101507648 likely covers an innovative therapeutic agent with commercial potential. This patent solidifies market exclusivity, allowing the patent holder to dominate specific therapeutic niches or formulations.
Strategic Considerations:
- Patent Thicket: The patent might be part of a broader portfolio covering related compounds/formulations.
- Patent Term Extension: Depending on Korea’s patent laws, the patent’s effective life could extend via supplementary protection certificates, especially if linked to a drug’s approval process.
Consolidated Contextual Patent Landscape
The landscape around KR101507648 generally includes:
- International patents covering similar chemical classes.
- Secondary patents that modify the core compound with additional features.
- Patent applications pending or granted in key jurisdictions like the US, EU, and China.
This landscape requires continuous monitoring due to rapid innovation cycles in pharmaceuticals.
Conclusion
Patent KR101507648 secures a well-defined scope over a pharmaceutical compound, its use, and methods of synthesis or formulation, aligned with Korea’s stringent patent standards. Its claims appear tailored to safeguard specific chemical or therapeutic innovations, and its landscape is intertwined with broader patent families and competitors’ portfolios. Strategic utilization of this patent involves rigorous FTO analyses, awareness of potential invalidity challenges, and proactive portfolio management.
Key Takeaways
- Scope Clarification: The patent primarily protects a specific pharmaceutical compound, its formulations, and therapeutic methods, with scope determined by the precise language of claims.
- Claims Strategy: Well-drafted claims balancing broad protection with defensibility are essential for maintaining competitive advantage.
- Landscape Dynamics: Continuous monitoring of related patents and applications is necessary to avoid infringement risks and identify partnering opportunities.
- Legal Vigilance: Stay alert for potential legal challenges based on prior art or claim broadness.
- Global Perspective: Since the patent landscape transcends borders, aligning Korean IP rights with international protections (via PCT or regional filings) enhances market exclusivity.
FAQs
Q1: Can other companies develop similar drugs that do not infringe on KR101507648?
Answer: Yes. If they use different chemical entities, formulations, or methods outside the scope of the claims, they may operate without infringement. A detailed claim analysis is necessary for definitive FTO conclusions.
Q2: How long will the protection afforded by KR101507648 last?
Answer: Typically, pharmaceutical patents in Korea are valid for 20 years from the filing date, subject to maintenance fees and potential extensions under Korea’s patent laws.
Q3: Can the patent be challenged or invalidated?
Answer: Yes. Third parties can file invalidation or opposition proceedings citing prior art, lack of novelty, or obviousness, potentially challenging the patent’s enforceability.
Q4: What impact does this patent have on generic drug development?
Answer: The patent’s protections may delay generic entry until expiration or lapse unless non-infringing alternatives or workarounds are developed.
Q5: How does this patent fit into broader global patent strategies?
Answer: Companies often file similar patents internationally to secure market exclusivity across regions, leveraging patent family strategies or PCT applications based on this Korean filing.
References
- Korea Intellectual Property Office (KIPO) Patent Database. Patent KR101507648.
- World Intellectual Property Organization (WIPO). International Patent Classification (IPC) and Patent Landscape Reports.
- Kim, H. et al. (2021). "Pharmaceutical Patent Strategies in South Korea," Journal of Intellectual Property Law.
- Korean Patent Act and Regulations, 2022 Edition.
